市場調查報告書
商品編碼
1503390
到 2030 年內視鏡設備市場預測 - 按產品類型、治療和程序、技術、最終用戶和地理位置進行的全球分析Endoscopy Devices Market Forecasts to 2030 - Global Analysis By Product Type, Treatment & Procedure, Technology, End User and By Geography |
根據 Stratistics MRC 的數據,2024 年全球內視鏡設備市場規模為 319 億美元,預計到 2030 年將達到 468 億美元,預測期內複合年成長率為 6.6%。內視鏡設備是用於在人體內部器官和腔內進行可視化、診斷和治療干預的專用醫療儀器。這些設備通常由一根末端帶有燈和攝影機的軟性管組成,可實現微創手術。它們通常用於胃腸病學、肺病學和婦科,以檢查胃腸道、呼吸系統和生殖器官等區域。
根據世界衛生組織 (WHO) 統計,全球市場上估計有 200 萬種不同類型的醫療器械,分為 7,000 多個通用器械組。
慢性病盛行率增加
胃腸道疾病、癌症和心血管疾病等慢性疾病的盛行率不斷上升,是內視鏡設備市場的重要驅動力。這些情況通常需要診斷和治療內視鏡手術,導致對內視鏡設備的需求增加。內視鏡手術能夠提供微創解決方案,恢復時間更快,併發症更少,進一步提高了其採用率,推動市場成長。
內視鏡設備成本高
內視鏡設備的高成本是市場的主要限制因素。先進的內視鏡設備和系統,例如高清視覺化系統和機器人輔助內視鏡,價格昂貴。這可能會限制它們的採用,特別是在預算有限的發展中地區。高昂的初始投資和維護成本也可能成為小型醫療機構的障礙,影響整體市場成長。
轉向個人化醫療
向個人化醫療的轉變為內視鏡設備市場提供了重大機會。個人化醫療涉及根據每個患者的個別特徵制定醫療治療方案,這需要精確的診斷工具。內視鏡設備能夠提供詳細的內部視野和有針對性的活體組織切片,非常適合個人化的診斷和治療程序。這一趨勢預計將推動先進內視鏡技術的創新和採用。
缺乏熟練的專業人員
缺乏熟練的專業人員是內視鏡設備市場的一個顯著威脅。內視鏡手術需要訓練有素且經驗豐富的醫療保健專業人員,以確保準確的診斷和有效的治療。缺乏訓練有素的內視鏡醫師和技術人員可能會限制先進內視鏡設備的最佳利用,導致性能不佳和潛在的併發症。這種短缺也阻礙了新技術的採用,限制了市場的成長。
Covid-19 大流行對內視鏡設備市場產生了重大影響。在大流行的早期階段,包括許多內視鏡檢查在內的選擇性手術被推遲或取消,以優先為 Covid-19 患者提供資源並降低病毒傳播的風險。這導致內視鏡設備的需求暫時下降。然而,隨著醫療保健系統適應並實施安全措施,在恢復延遲的手術以及人們對早期診斷重要性的認知提高的推動下,市場開始復甦。
預計內視鏡領域在預測期內將是最大的
預計內視鏡細分市場在預測期內將是最大的。內視鏡是內視鏡手術中使用的主要工具,可直接觀察內部器官和組織。慢性病的盛行率不斷上升以及對微創手術的日益偏好推動了對內視鏡的需求。高清成像和軟性內視鏡等技術進步進一步提高了其實用性和採用率,為市場成長做出了重大貢獻。
預計門診手術中心 (ASC) 領域在預測期內的複合年成長率最高
預計門診手術中心 (ASC) 領域在預測期內的複合年成長率最高。 ASC 為醫院手術提供了經濟高效的替代方案,提供門診手術服務。人們越來越傾向於在 ASC 中進行微創手術,這推動了這些環境中對內視鏡設備的需求。 ASC 的便利性、住院時間的縮短和成本的降低使其成為患者和醫療保健提供者的有吸引力的選擇,從而推動了市場的成長。
北美地區在內視鏡設備市場佔有主導地位。先進的醫療基礎設施、醫療技術的廣泛採用以及胃腸道和慢性疾病發病率的上升等因素促成了該地區的市場領導地位。主要市場參與者的存在和內視鏡手術的優惠報銷政策進一步支持了北美市場的成長。
亞太地區預計內視鏡設備市場將快速成長。該地區的成長得益於醫療保健投資的增加、醫療基礎設施的改善以及早期診斷和治療意識的提高。慢性病的高盛行率,加上老年人口的不斷成長,增加了對內視鏡手術的需求。此外,先進內視鏡技術的採用以及中國和印度等新興經濟體醫療保健服務的擴展也促進了該地區的高成長率。
2024 年 4 月,致力於將外科醫生與患者之間的界面數位化的醫療器械公司 Asensus Surgical, Inc. 宣布與 KARL STORZ SE 簽訂了一份不具約束力的意向書(以下簡稱“意向書”) & Co. KG,一家獨立的家族式全球醫療技術公司(“KARL STORZ”)就KARL STORZ 可能收購Asensus 的潛在交易條款進行盡職調查和談判。在簽署意向書之前,Asensus 對各種策略選項進行了廣泛的考慮,包括潛在的合作和授權交易、依賴籌集大量額外股本的單幹策略、出售公司和其他潛在業務開發交易。
2024年3月,新維維醫療科技有限公司(簡稱「新維維醫療」)與全球領先的醫療科技公司波士頓科學公司再次攜手,簽署擴大策略合作安排。
2023年10月,致力於讓人們的生活更健康、更安全、更充實的全球醫療科技公司奧林巴斯公司今天宣布向市場推出其下一代EVIS X1(TM)內視鏡系統,該系統將於10月進行展示和演示。
According to Stratistics MRC, the Global Endoscopy Devices Market is accounted for $31.9 billion in 2024 and is expected to reach $46.8 billion by 2030 growing at a CAGR of 6.6% during the forecast period. Endoscopy devices are specialized medical instruments used to visualize, diagnose, and perform therapeutic interventions within the body's internal organs and cavities. These devices typically consist of a flexible tube with a light and a camera at the end, allowing for minimally invasive procedures. They are commonly employed in gastroenterology, pulmonology, and gynecology to inspect areas such as the gastrointestinal tract, respiratory system, and reproductive organs.
According to the World Health Organization (WHO), there are an estimated 2 million different kinds of medical devices on the world market, categorized into more than 7,000 generic device groups.
Increasing prevalence of chronic diseases
The rising prevalence of chronic diseases such as gastrointestinal disorders, cancer, and cardiovascular diseases is a significant driver for the endoscopy devices market. These conditions often require diagnostic and therapeutic endoscopic procedures, leading to increased demand for endoscopy devices. The ability of endoscopic procedures to provide minimally invasive solutions with quicker recovery times and fewer complications further boosts their adoption, driving market growth.
High cost of endoscopic equipment
The high cost of endoscopic equipment is a major restraint for the market. Advanced endoscopic devices and systems, such as high-definition visualization systems and robotic-assisted endoscopes, come with substantial price tags. This can limit their adoption, especially in developing regions with budget constraints. The high initial investment and maintenance costs can also be a barrier for smaller healthcare facilities, impacting overall market growth.
Shift towards personalized medicine
The shift towards personalized medicine presents a significant opportunity for the endoscopy devices market. Personalized medicine involves tailoring medical treatment to the individual characteristics of each patient, which requires precise diagnostic tools. Endoscopy devices, with their ability to provide detailed internal views and targeted biopsies, are well-suited for personalized diagnostic and therapeutic procedures. This trend is expected to drive innovation and adoption of advanced endoscopic technologies.
Lack of skilled professionals
The lack of skilled professionals is a notable threat to the endoscopy devices market. Endoscopic procedures require highly trained and experienced healthcare professionals to ensure accurate diagnosis and effective treatment. The shortage of trained endoscopists and technicians can limit the optimal utilization of advanced endoscopy equipment, leading to underperformance and potential complications. This shortage also hampers the adoption of new technologies, restraining market growth.
The Covid-19 pandemic had a significant impact on the endoscopy devices market. During the early stages of the pandemic, elective procedures, including many endoscopic examinations, were postponed or canceled to prioritize resources for Covid-19 patients and reduce the risk of viral transmission. This led to a temporary decline in demand for endoscopy devices. However, as healthcare systems adapted and implemented safety measures, the market began to recover, driven by the resumption of postponed procedures and increased awareness of the importance of early diagnosis.
The endoscopes segment is expected to be the largest during the forecast period
The endoscopes segment is expected to be the largest during the forecast period. Endoscopes are the primary tools used in endoscopic procedures, providing direct visualization of internal organs and tissues. The increasing prevalence of chronic diseases and the growing preference for minimally invasive procedures drive the demand for endoscopes. Technological advancements, such as high-definition imaging and flexible endoscopes, further enhance their utility and adoption, contributing significantly to market growth.
The ambulatory surgery centers (ASCs) segment is expected to have the highest CAGR during the forecast period
The ambulatory surgery centers (ASCs) segment is expected to have the highest CAGR during the forecast period. ASCs offer cost-effective and efficient alternatives to hospital-based surgeries, providing outpatient surgical services. The increasing preference for minimally invasive procedures, which can be performed in ASCs, drives the demand for endoscopy devices in these settings. The convenience, reduced hospital stay, and lower costs associated with ASCs make them an attractive option for patients and healthcare providers, fueling market growth.
The North America region is positioned to dominate the Endoscopy Devices Market. Factors such as advanced healthcare infrastructure, high adoption of medical technologies, and a growing incidence of gastrointestinal and chronic diseases contribute to the region's market leadership. The presence of key market players and favorable reimbursement policies for endoscopic procedures further supports market growth in North America.
The Asia Pacific region anticipates rapid growth in the Endoscopy Devices Market. The region's growth is driven by increasing healthcare investments, improving medical infrastructure, and rising awareness of early diagnosis and treatment. The high prevalence of chronic diseases, coupled with a growing geriatric population, boosts the demand for endoscopic procedures. Additionally, the adoption of advanced endoscopic technologies and the expansion of healthcare services in emerging economies like China and India contribute to the region's high growth rate.
Key players in the market
Some of the key players in Endoscopy Devices Market include Olympus Corporation, KARL STORZ SE & Co. KG, Boston Scientific Corporation, Johnson & Johnson (Ethicon), Stryker Corporation, Medtronic plc, Fujifilm Holdings Corporation, HOYA Corporation, Nipro Corporation, Smith & Nephew plc, Intuitive Surgical, Inc., Richard Wolf GmbH, Cook Medical, B. Braun Melsungen AG, ConMed Corporation, Ambu A/S, CapsoVision, Inc., Fortimedix Surgical B.V., The Cooper Companies, Inc. and Laborie Medical Technologies Inc.
In April 2024, Asensus Surgical, Inc. a medical device company that is digitizing the interface between the surgeon and the patient, announced that it has entered into a non-binding letter of intent (the "letter of intent") with KARL STORZ SE & Co. KG, an independent, family-owned global medical technology company ("KARL STORZ") to engage in diligence and negotiations regarding the terms of a potential transaction whereby KARL STORZ may acquire Asensus. Entry into the letter of intent follows an extensive period of consideration of various strategic alternatives by Asensus, including potential collaboration and licensing transactions, a go-it-alone strategy dependent upon raising significant additional equity capital, a sale of the Company and other potential business development transactions.
In March 2024, Scivita Medical Technology Co., Ltd. ("Scivita Medical") and Boston Scientific Corporation, a leading global medical technology company, joined hands again to sign an expanded strategic cooperation arrangement.
In October 2023, Olympus Corporation, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced today the market launch of its next-generation EVIS X1(TM) endoscopy system, which will be on display and demonstrated Oct. 22-24 during the American College of Gastroenterology (ACG) annual meeting in Vancouver, Canada.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.